Member Info for Bella6532

Instead of having one person in charge of two completely different sides of the business, we now have each side of the business with it's own head which, as I said early, leads to far more accountability.

The historic transactions is peanuts and many companies make reporting mistakes especially if only one person in the organisation knows the rules which is nearly always the case. I suspect as said due diligence has been done to either cover buts for a T/O or RTO linked to fundraise/investment. I just get the the feeling there is more than just a simple fundraiser going on.

The historic transactions is peanuts and many companies make reporting mistakes especially if only one person in the organisation knows the rules which is nearly always the case. I suspect as said due diligence has been done to either cover buts for a T/O or RTO linked to fundraise/investment.

Snowboots...'The director changes are, I’d imagine, a condition of the raise.'...could be but it looks to be more about splitting and operating the company as two separate parts. Makes more sense to me and provides more accountability.

He also goes on to say:
'What will be interesting to see with regard to DeepVerge is whether the current share price back at 2018 levels remains so low in the event of a successful fundraise? The stock under 3p looks not to be pricing such a scenario correctly.'

It an AI generated article. Standard pros and it just infills the ownership info. Nothing new here just misleading...

Oooo...they're closing...

20-Oct-22 17:05:57 102.00 25,500 Unknown* 26.01k O
20-Oct-22 17:02:02 102.7073 402,962 Unknown* 413.87k O
20-Oct-22 16:52:53 101.899 55,046 Unknown* 56.09k O
20-Oct-22 16:51:55 101.899 55,046 Unknown* 56.09k O
20-Oct-22 16:35:27 102.00 17,259 Sell* 17.60k UT
20-Oct-22 16:31:48 102.50 20,000 Unknown* 20.50k O
20-Oct-22 16:29:22 103.536 148,505 Unknown* 153.76k

Ruba190...agree. Many S&Ms have cashflow problems created by large customers delaying payments...Govts being notorious. There have been moves in Govt circles to try and legislate against late payments but of course it never sees the light of day...
The mess the UK Govt have and are continuing to create has made the markets jittery so a fundraiser right now could be somewhat difficult unless the company has a good story to telk going forward.. and we have. Fundraisers via roadshows are never quick and easy but they do pay off. TW is paid to put out his ramblings and I suspect someone wanting in at a good price...below the fundraiser price has actively fed TW with info. By getting the SP down both could then benefit especially if TW is shorting us. Keep your eyes on open for big late trades over coming days..

Avacta joins a growing life science cluster in this area of over twenty biotechs and pharma firms which includes Novartis, Autolus,and Eden Bio. Clusters are important as they provide networks that are generous and collaborative and make growing hubs like Imperial College London’s White City Campus attractive for like-minded talent looking to innovate and scale their business.”

Mr R...So you think Jupiter is in bed with TW...?
TW doesn't make money shorting he makes money selling his services to either pump or bash. Rather like Money Week except they tend to be more subtle. How else did TW get wind of a fundraise...oh! His mates at Jupiter. A bit of cross referencing with Jupiters investments/shorts and TWs articles/tweets may or may not confirm the above.

Hate to say it but sometimes you wonder if the likes of Jupiter weren't in on this raising all along...they increased their short only a matter of days ago and now they appear to have no problem closing out. What's your betting this bumps up as tge new shares are admitted...

Mustang74...we were told any fundraise undertaken would lead to minimum dilution and this is a way of doing that. It's a win win and I for one see it as a positive. They've just bought a Debt Free company with Income of around £30m and basically used said assets/income as a Bond. Ok that's very simplistic because this fundraise in total is on several levels and the Bond being one.

Myles...it looks like we have our timescales...do you think we will rumble along until mid November at these prices and thereafter news will be forthcoming?

Expected Timetable of Principal Events(1)(2)



Date

Record Date for entitlements under the Open Offer

6.00 p.m. on 14 October 2022

Announcement of the Fundraise

7.00 a.m. on 18 October 2022

Announcement of the results of the Bookbuild

18 October 2022

Ex-Entitlement Date for the Open Offer

19 October 2022

Posting of the Circular and, to certain Qualifying non-CREST Shareholders only, the Application Form

19 October 2022

Admission of the Placing Shares and the Management Subscription Shares

20 October 2022

Expected settlement of the Convertible Bonds

20 October 2022

Open Offer Entitlements and Excess CREST Open Offer Entitlements credited to stock accounts in CREST of Qualifying CREST Shareholders

21 October 2022

Recommended latest time and date for requesting withdrawal of Open Offer Entitlements and Excess CREST Open Offer Entitlements from CREST

4.30 p.m. on 1 November 2022

Latest time and date for depositing Open Offer Entitlements into CREST

3.00 p.m. on 2 November 2022

Latest time and date for splitting Application Forms (to satisfy bona fide market claims only)

3.00 p.m. on 3 November 2022

Latest time and date for receipt of completed Application Forms and payment in full from Qualifying Shareholders under the Open Offer or settlement of relevant CREST instruction (as appropriate)

11.00 a.m. on 7 November 2022

Announcement of the results of the Open Offer

8 November 2022

Admission effective and dealings in the Open Offer Shares expected to commence on AIM

9 November 2022

Expected date for crediting of the Open Offer Shares in uncertificated form to CREST stock accounts

9 November 2022

Expected date of dispatch of share certificates in respect of the Open Offer Shares

by 16 November 2022

,Launch Diagnostics generated £14.17 million of non-COVID-19 related revenue in FY21, with total revenues including COVID-19 related products of £32.75 million. Since FY19, the gross margin in total sales has consistently been in the range 44-50% across all products.'

'continue to execute an M&A led growth strategy' for its Diagnostics business,'Mmmm! Diagnostics very much back in the running...something must have been targetted for them to go ahead and raise funds...very interesting...

'continue to execute an M&A led growth strategy' for its Diagnostics business,'Mmmm! Diagnostics very much back in the running...something must have been targetted for them to go ahead and raise funds...very interesting...

Chesh..'Bella6532......! the debt defo needs clearing, for what reason...?'...
It's an unnecessary costly debt deal done with US enterties and using investors money is basically free. We have been told many if their customers are A Lister companies and if you have any knowledge of how US markets operate and the fact many listings are achieved via RTO's....bla bla wink wink...I suspect Chesh we are on the same wavelength...

What if they were approached by a very large invester who wanted in at a low price but who insisted their investment be used to clear the current loan...!!!
If said investor has indicated they would invest further in the company once bla bla was achieved then maybe the offer was too good to ignore!!
Plenty of money around in the Midfle East US and China looking for a home...